All rights reserved effect of reinforcing kidney-essence, removing phlegm, and promoting mental therapy on treating Alzheimer's disease

Journal of Traditional Chinese Medicine

Volumn 33, Issue 4, 2013, Pages 449-454

  Liu, Ping ^a   Kong, Mingwang ^a   Liu, Songlin ^a   Chen, Gang ^a   Wang, Ping ^a  

^a HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Alzheimer disease; Drugs, Chinese herbal; Reinforcing kidney; Resolving phlegm

Indexed keywords

BUSHENHUATANYIZHI; CHINESE DRUG; LIPID PEROXIDE; PIRACETAM; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; HERBACEOUS AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; COGNITION; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY; DRUG EFFECTS; PSYCHOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED;

EID: 84883040795     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Solomon A, Kivipelto M, Soininen H. Prevention of Alzheimer's disease: moving backward through the life span. J Alzheimers Dis 2013; 33(Suppl 1): 465-469.
2. Opara J. Activities of daily living and quality of life in Alzheimer's disease. J Med Life 2012; 5(2): 162-167.
3. Strittmatter W J. Alzheimer's disease: the new promise. J Clin Invest 2012; 122(4): 1191.
4. Brookmeyer R, Johnson E, Ziegler-Graham K, M H Arrighi. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007; 3(3): 186-191.
5. Tarawneh R, Holzman D M. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med 2012; 2(5): 6148-6165.
6. Galvin J E, Sadowsky C H. Pratical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med 2012; 25(3): 367-382.
7. Nicole L Batsch, Mary S Mittelman. World Alzheimer Report 2012: Overcoming the stigma of dementia. 2012, London.
8. Wu T Y, Chen C P, Jinn T R. Traditional Chinese Medicines and Alzheimer's disease. Taiwan J Obstet Gynecol 2011; 50(2): 131-135.
9. Han Y, Lin L, Xi C T. Treating senile dementia with Traditional Chinese Medicine. Clin Interv Aging 2007; 2(2): 201-208.
10. Chen X Y. Shen Nong Ben Cao Jing. Beijing: China Academy Press, 2011: 60-80.
11. Zhang J B. Jing Yue Quan Shu. Beijing: Peoples Medical Publishing House, 2007: 37-65.
12. Chen S D. Bianzheng Lu. Beijing: China Traditional Chinese Medicine Press, 2007: 70-90.
13. Miao Y C, Tian J Z, Shi J, Mao M. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-bling and parallel-controlled trial. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2012; 10(4): 390-397.
14. Deng Y P, Yang R P. Recognition of differentiation theory of kidney turbidity in the diagnosis and treatment of Alzheimer's disease. Zhong Guo Lin Chuang Kang Fu 2005, 9(21): 200-201.
15. Wang P, Liu L, Shi X M. The influence of Xinnao Yizhi prescription on IAAS in hippocampi, cortex and striate body of brain of SAM-P/10. Zhong Guo Shi Yan Fang Ji Xue Za Zhi 2001; 7(4): 24-27.
16. Wang P, Liu L, Shi X M. The influence of Jiawei Wendan prescription on EAAs in hippocampi, cortex and striate body of brain of SAM-P/10. Zhong Guo Yi Yuan Yao Xue Za Zhi 2002; 22(11): 645-648.
17. Wang P, Hu H, Kong M W. The effect and potential mechanism of replenishing kidney-essence removing phlegm therapy on GSK-3β on Hyperphos-phorylation for AD Rat Model. Zhong Hua Zhong Yi Yao Xue Kan 2009; 27(9): 1845-1847.
18. Wang P, Hu H, Kong M W. Effects and function mechanism of replenishing kidney-essence and removing phlegm therapy on behavior in the rats of AD. Chengdu Xi Xue Yuan Xue Bao 2009; 4(2): 79-84.
19. Liu P, Zhao L, Xiang J Z, et al. Modified Wendan Decoction can attenuate neurotoxic action associated with Alzheimer's disease. Evid-Based Compl Alt 2009; 6(3): 325-330.
20. Wang P, Hu H, Kong M W. Effect and potential mechanism of replenishing the kidney and eliminating phlegm therapy on CaMK II-α activities of AD rat model. Zhong Hua Zhong Yi Yao Za Zhi 2010; 25(5): 786-788.
21. Waegemans T, Wilsher C R, Danniau A, et al. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Dement Geriatr Cogn 2002; 13(4): 217-224.
22. Gabryel B. Piracetam and vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation. Neurotoxicology 2002; 23(1): 19-31.
23. Dean P M, Feldman D M, Morere D, Morton D. "Clinical evaluation of the mini-mental state exam with culturally deaf senior citizens". Arch Clin Neuropsychol 2009; 24(8): 753-760.
24. Guerrero-Berroa E, Luo X, Schmeidler J, et al. The MMSE orientation for time domain is a strong predictor of subsequent cognitive decline in the elderly. Int J Geriatr Psychiatry 2009; 24(12): 1429-1437.
25. Reisberg B, Finkel S, Overall J, et al. The Alzheimer's disease activities of daily living international scale (ADL-IS). Int Psychogeriatr 2001; 13(2): 163-181.
26. Hu H, Wang P, Kong M W, Ding F M. The effect and potential mechanism of replenishing kidney-essence removing phlegm therapy on tau hyperphos-phorylation for AD rat. Shi Zhen Guo Yi Guo Yao 2010; 21(10): 2681-2683.
27. Salloway S, Ferris S, Kluger A, et al. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 2004; 63(4): 651-657.
28. Tian J Z, Shi J, Zhang X Q, et al. Guiding principles of clinical research on mild cognitive impairment (protocol). J Chin Integr Med 2008; 6(1): 9-14.
29. Wang H T. Huang Di Nei Jing Su Wen. Beijing: People's Medical Publishing House, 2005: 45-66.
30. Deng Y P, Yang R P. Recognition of differentiation theory of kidney turbidity in the diagnosis and treatment of Alzheimer disease. Zhong Guo Lin Chuang Kang Fu 2004; 9(21): 200-202.
31. Lars Backman. Cognition in preclinical dementia: current knowledge and future prospects. Xin Li Xue Bao 2009; 41(11): 1040-1048.
32. Miao Y C, Tian J Z, Shi J, Mao M. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized double-blind and parallel-controlled trial. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2012; 10(4): 390-398.
33. Lin S M, Wang J, Zhou R Q, Yu Z H. Clinical effect in treatment of Alzheimer disease based on the conditions of heart and kidney. Zhong Guo Lin Chuang Kang Fu 2006; 10(11): 162-164.
34. Leopoldo L S N, Maria A V T, Patricia M S, et al. The use of herbal medicine in Alzheimer's disease-a systematic review. Evid-Based Compl Alt 2006; 3(4): 441-445.
35. Tian J Z, Shi J, Zhang X, Yang Y Y. Herbal therapy: a new pathway for the treatment of Alzheimer's disease. Alzheimers Res Ther 2010; 2(5): 30.
36. Gunter Peter Echkert. Traditional used plants against cognitive decline and Alzheimer disease. Front Pharmacol, 2010.
37. Yu L, Lin S W, Zhou R Q, et al. Chinese herbal medicine for patients with mild to moderate Alzheimer's disease based on syndrome differentiation: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao 2012; 10(7): 76-82.
38. Akhondzadeh S, Abbasi S H. Herbal medicine in the treatment of Alzheimer's disease. Am J Alzheimers Dis Other Demen 2006; 21(2): 113-118.
39. Zhuang Z Z, Liu C M, Li F. Chinese herbs in the treatment of senile dementia. Zhong Guo Lin Chuang Kang Fu 2004; 8(13): 2598-2600.
40. Yang W M, Chen B, Han M X, Bao Y C. Experimental and clinical study of the anti-dementai effect of unconventional nootropics. Zhong Guo Lin Chuang Kang Fu 2004; 8(13): 1390-1393.
41. Tian S M, Ma Y X, Sun L Z, et al. Effects of different fractions of Acori graminei rhizoma extracts on learning and memory abilities in Aβ-induced Alzheimer disease mice. Zhong Guo Bing Li Sheng Li Za Zhi 2012; 28(1): 159-162.
42. Ma Y X, Li G Y, Sun L Z, et al. Effects of the different extracted parts from Acori graminei rhizoma on learning and memory deficits in Aβ-injected mice. Shen Jing Jie Pou Za Zhi 2011; 27(5): 521-526.
43. Jiang Y, Yang Y Q, He Y P. Protective effect of combination of effective components in Acorus tatarinowii on PC12 cell injuryed by beta amyloid protein. Zhong Yao Xin Yao Yu Lin Chuang Yao Li 2006; 17(5): 335-338.
44. Cao D J, Li X Y, Guo F, et al. In vivo effects of Radix Polygalae on learning memory and the hippocampal long term potentiation in AD model rats. Shi Jie Zhong Xi Yi Jie He Za Zhi 2010; 5(8): 661-664.
45. Wen J, Yang B N, Xue C Q, et al. The study of polygala tenuifolia willd promote neurogenesis in Alzheimer's disease model mice. Shen Jing Jie Pou Za Zhi 2010; 26(2): 145-149.
46. Yang X Y. The Effects of refined polygonum multiflorum thunb polysaccharide on learning memory and the activities of enzymes in the brain for the experimental mice with dementia. Yao Xue Jin Zhan 2005; 29(12): 557-559.
47. Zhu Q C, Ren C Q, Bao L, et al. Effect of polygonum multiflorum thumb on learning and memory capacity in mice with AD. Heilongjiang Yi Yao Ke Xue 2011; 34(3):8-9.
48. Shi C N, Li X G, Xu Q S, et al. Effects of polygala tenuifolia extracts on learning and memory abilities in Alzeimer's disease model mice. Zhong Feng Yu Shen Jing Ji Bing Xue Za Zhi 2011; 28(7): 620-622.
49. Lin Z, Xiao Z, Zhu D, Yan Y, Yu B, and Wang Q. Aqueous extracts of FBD, a Chinese herb formula composed of Poria cocos, Atractylodes macrocephala, and Angelica sinensis reverse scopolamine induced memory deficit in ICR mice. PHARM BIOL 2009; 47(5): 620-622.